Journal article
Impact of metagenomic next-generation sequencing on clinical decision-making at an academic medical center, a retrospective study, Iowa, 2020–2022
Antimicrobial stewardship & healthcare epidemiology : ASHE, Vol.4(1), e39
03/27/2024
DOI: 10.1017/ash.2024.31
PMCID: PMC10983051
PMID: 38562514
Appears in UI Libraries Support Open Access
Abstract
We assessed the impact of metagenomic next-generation sequencing (mNGS) on patient care using previously established criteria. Among 37 patients receiving mNGS testing, 16% showed results that had a positive clinical impact. While mNGS results may offer valuable supplementary information, results should be interpreted within the broader clinical context and evaluation.
Details
- Title: Subtitle
- Impact of metagenomic next-generation sequencing on clinical decision-making at an academic medical center, a retrospective study, Iowa, 2020–2022
- Creators
- Michael OlthoffTakaaki KobayashiMeredith ParsonsBradley FordKunatum PrasidthrathsintLemuel NonJorge Salinas - Stanford UniversityDaniel DiekemaDilek Ince
- Resource Type
- Journal article
- Publication Details
- Antimicrobial stewardship & healthcare epidemiology : ASHE, Vol.4(1), e39
- DOI
- 10.1017/ash.2024.31
- PMID
- 38562514
- PMCID
- PMC10983051
- NLM abbreviation
- Antimicrob Steward Healthc Epidemiol
- eISSN
- 2732-494X
- Publisher
- Cambridge University Press
- Language
- English
- Date published
- 03/27/2024
- Academic Unit
- Infectious Diseases; Pathology; Internal Medicine
- Record Identifier
- 9984577036302771
Metrics
12 Record Views